Capecitabine in combination with oxaliplatin and bevacizumab (AXELOX) as 1st line treatment for fit and vulnerable elderly patients (aged >70 years) with metastatic colorectal cancer (mCRC): a multicenter phase II study of the Hellenic Oncology Rese
about
Anti-angiogenic agents in metastatic colorectal cancerThe place of targeted agents in the treatment of elderly patients with metastatic colorectal cancerEfficacy of FOLFOXIRI versus XELOXIRI plus bevacizumab in the treatment of metastatic colorectal cancer.A prospective study of XELOX plus bevacizumab as first-line therapy in Japanese patients with metastatic colorectal cancer (KSCC 0902).Capecitabine, Oxaliplatin, and Bevacizumab (BCapOx) Regimen for Metastatic Colorectal Cancer.Clinical parameters to guide decision-making in elderly metastatic colorectal CANCER patients treated with intensive cytotoxic and anti-angiogenic therapy.Cytotoxic effects of the newly-developed chemotherapeutic agents 17-AAG in combination with oxaliplatin and capecitabine in colorectal cancer cell lines.
P2860
Q26801911-82114543-7E1F-48D2-B6A1-84B7E0D11AEBQ27011366-E9402966-3634-4AF8-A047-0CAF04EAD62DQ36411962-649C6C4E-6CC0-4A9F-923E-AEA2E134A2A7Q36778075-7A7BE9F8-1DD9-4BAF-9141-3C5EBC971AD4Q38626963-0F539B92-9F97-4734-A090-EF536DE1949EQ41044367-B6AB3223-CAA1-4E83-8DDF-1993AB739A46Q47106034-A2061DEE-EC60-447D-B66C-2BB2C7A06ABF
P2860
Capecitabine in combination with oxaliplatin and bevacizumab (AXELOX) as 1st line treatment for fit and vulnerable elderly patients (aged >70 years) with metastatic colorectal cancer (mCRC): a multicenter phase II study of the Hellenic Oncology Rese
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Capecitabine in combination wi ...... of the Hellenic Oncology Rese
@ast
Capecitabine in combination wi ...... of the Hellenic Oncology Rese
@en
type
label
Capecitabine in combination wi ...... of the Hellenic Oncology Rese
@ast
Capecitabine in combination wi ...... of the Hellenic Oncology Rese
@en
prefLabel
Capecitabine in combination wi ...... of the Hellenic Oncology Rese
@ast
Capecitabine in combination wi ...... of the Hellenic Oncology Rese
@en
P2093
P2860
P921
P356
P1433
P1476
Capecitabine in combination wi ...... of the Hellenic Oncology Rese
@en
P2093
Alexios Matikas
Aris Polyzos
Athanasios Karampeazis
Charalampos Christophylakis
Dora Hatzidaki
Ioannis Boukovinas
John Souglakos
Lambros Vamvakas
Stelios Kakolyris
Vassilis Georgoulias
P2860
P2888
P356
10.1186/1471-2407-14-277
P407
P577
2014-04-22T00:00:00Z
P5875
P6179
1051180348